Overview

Comparative Clinical Trial of Efficacy and Safety of Ergoferon Versus Oseltamivir in Treatment of Influenza

Status:
Completed
Trial end date:
2018-04-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is: - to assess the efficacy of Ergoferon in treatment of influenza; - to assess the safety of Ergoferon in treatment of influenza; - to compare the efficacy of Ergoferon and Oseltamivir for treatment of influenza.
Phase:
Phase 4
Details
Lead Sponsor:
Materia Medica Holding
Treatments:
Oseltamivir